Rollins, Inc. · ROL · FY2026 Q2 · Calendar Q3 2026

Rollins Q2 2026: Revenue Misses as Digital Lead Slowdown Hits Orkin

Rollins' Q2 2026 results fell short of consensus on both lines, with revenue of $1.08B (up 7.9% YoY, organic 5.7%) missing by ~1.4% and EPS of $0.32 missing by ~4.7%. The shortfall was concentrated in digitally-initiated residential demand at Orkin, a sharp contrast to Q1's 10.2% revenue growth and 6.6% organic growth. Management lowered full-year organic growth guidance from 7-8% to at least 6% while introducing a minimum 10% incremental margin commitment. The stock declined ~8% on 3.6x baseline volume. Multi-brand diversification through HomeTeam and Fox provided partial resilience with double-digit residential growth, and M&A including the Romex acquisition continues to contribute 2-3% of revenue growth, but the digital lead generation slowdown and its potential connection to AI/LLM search disruption introduce a new layer of uncertainty.

Reported After market closeNYSEIndustrials $18.45B market cap
100quality score

Company context

Snapshot as of publication

Rollins, Inc. operates a network of subsidiaries that specialize in delivering pest and wildlife management solutions to a diverse clientele, encompassing both homeowners and commercial enterprises, throughout the United States and globally. For residential properties, the company offers comprehensive pest control, safeguarding homes from prevalent invaders such as rodents, insects, and other nuisance animals. Furthermore, it devises tailored pest management strategies for various business sectors, including healthcare, foodservice, and logistics. Beyond standard pest solutions, Rollins, Inc. also provides a range of termite defense options, from conventional treatments to baiting systems, alongside other complementary services. The firm serves its customers directly through its own operations as well as through its extensive franchisee network. Established in 1948, Rollins, Inc. maintains its headquarters in Atlanta, Georgia.

Earnings scorecard

Reported versus consensus
Reported EPS $0.32 Consensus $0
EPS surprise -4.7% Reported versus consensus
Reported revenue $1.08B Consensus $1.09B
Revenue surprise -1.4% Reported versus consensus

Earnings History

Estimate Beat Miss Match
ROL EPS earnings history estimate and actual scatter chart 9 reported fiscal quarters and 4 future estimate-only quarters. Q1 '24 estimate $0.20 Q1 '24 actual $0.20, match Q2 '24 estimate $0.27 Q2 '24 actual $0.27, match Q3 '24 estimate $0.30 Q3 '24 actual $0.29, match Q2 '25 estimate $0.30 Q2 '25 actual $0.30, match Q3 '25 estimate $0.33 Q3 '25 actual $0.35, beat Q4 '25 estimate $0.26 Q4 '25 actual $0.25, miss Q1 '26 estimate $0.23 Q1 '26 actual $0.24, match Q2 '26 estimate $0.34 Q2 '26 actual $0.32, miss Q3 '26 estimate $0.35 Q4 '26 estimate $0.26 Q1 '27 estimate $0.25 Q2 '27 estimate $0.35
Show 1 more >

Analyst Consensus ?

ConsensusHold21 ratings
Bullish733.3%
Neutral1257.2%
Bearish29.5%

Analyst 52W Price Targets

$38.35Current
$32Low
$54.16Average
$72High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 31, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
Wells Fargo Underweight Equal WeightDowngradeJul 24, 2026
UBS Neutral NeutralMaintainJul 24, 2026
Piper Sandler Overweight OverweightMaintainJul 24, 2026
JP Morgan Neutral OverweightDowngradeJul 24, 2026
Canaccord Genuity Hold HoldMaintainJul 24, 2026
BNP Paribas Neutral NeutralMaintainJul 24, 2026
Barclays Overweight OverweightMaintainJul 24, 2026
RBC Capital Sector Perform OutperformDowngradeJul 23, 2026
Show 13 more rating actions

Named analyst price targets

Upside is calculated against the persisted current price $38.35. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
UBSJoshua Chan$43$38.59 +12.1%Jul 24, 2026
BarclaysAnalyst unavailable$45$39.44 +17.3%Jul 24, 2026
Wells FargoJason Haas$32$39.44 -16.6%Jul 24, 2026
Canaccord GenuityAnalyst unavailable$45$38.62 +17.3%Jul 23, 2026
Raymond JamesAnalyst unavailable$35$43.47 -8.7%Jul 23, 2026
RBC CapitalAshish Sabadra$40$43.47 +4.3%Jul 23, 2026
UBSAnalyst unavailable$50$44.29 +30.4%Jul 15, 2026
Morgan StanleyGreg Parrish$65$43.62 +69.5%Jul 8, 2026
Wells FargoAnalyst unavailable$46$44.54 +19.9%Jun 25, 2026
BernsteinConnor Cerniglia$52$49.42 +35.6%May 29, 2026
See 24 more

Track every rating change on ROL the moment it posts. Free to start.

Start free

Market reaction

event-close to next-session close
Stock move -9.3% Event window
SPY move -1.2% Same window
Abnormal move -8.0% Stock minus SPY
Volume 3.6× Versus trailing sessions
Subsequent drift -2.8% Up to 20 sessions
ROLSPY benchmark

Follow ROL with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Transcript intelligence

What changed

The most significant shift from Q1 to Q2 was the deceleration in digitally-initiated residential pest-control demand, particularly at Orkin, which drove both the revenue and EPS miss. Q1 revenue grew 10.2% with 6.6% organic growth and a confident management tone (bullish score 78); Q2 revenue grew 7.9% with 5.7% organic growth and a cautious management tone (bullish score 65). Margin pressure sources shifted from insurance, claims, and fleet costs in Q1 to medical costs, fuel, and SG&A in Q2. Full-year organic growth guidance was reduced from 7-8% to at least 6%, though a new minimum 10% incremental margin target was introduced. New CFO William Harkins made his first earnings call appearance, and Scott Weaver was promoted to COO overseeing both residential and commercial operations in the U.S. and Canada. Management also flagged for the first time the potential impact of AI and large-language-model search results on digital lead generation.

Guidance delta

Full-year organic revenue growth guidance was lowered from 7-8% to at least 6%. The company introduced a minimum 10% incremental margin commitment as a new guidance element. M&A contribution of 2-3% of revenue growth was maintained. The transcript analysis classified overall guidance sentiment as raised, reflecting the addition of the incremental margin target even as the organic growth floor was reduced.

Key takeaways

  • Q2 revenue of $1.08B grew 7.9% YoY (organic 5.7%) but missed consensus by ~1.4%; EPS of $0.32 missed by ~4.7%.
  • Digital lead generation slowdown at Orkin drove the revenue miss, while HomeTeam and Fox posted double-digit residential growth.
  • Termite, ancillary, and commercial segments delivered solid double-digit gains, partially offsetting residential softness.
  • Margin pressure from higher medical costs, fuel expenses, and SG&A, but incremental margin guidance maintained at 10% or higher.
  • Full-year organic growth guidance updated from 7-8% to at least 6%; M&A contribution of 2-3% maintained.
  • Romex acquisition completed in Q2 as Rollins' largest Q2 acquisition, alongside several tuck-in deals.

Management priorities

  • Implement organizational and operational changes to improve accountability and resource alignment across residential and commercial operations.
  • Leverage new fleet supplier agreement with Wheels to reduce fleet costs.
  • Continue procurement initiatives to capture cost savings across the business.
  • Monitor and adjust digital marketing and SEO strategies, including the potential impact of AI and large-language-model search on lead generation.
  • Pursue disciplined M&A opportunities to meet the 2-3% revenue growth contribution target.
  • Accelerate cross-selling of ancillary services across all brands.

Related earnings events

Industrials

Sources

  1. Earnings call transcript and parsed analysis · 2026-07-23T15:03:37.539953+00:00
  2. FN2 earnings calendar · 2026-07-31T01:23:16.182055+00:00
  3. Polygon adjusted daily market bars · 2026-07-31T04:31:10.178247+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-31T04:31:10.176138+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.